Navigation Links
After the ABRF Conference: Gene Codes Flooded with Requests for Early Access to NextGen Software Tools
Date:3/7/2011

ANN ARBOR, Mich., March 7, 2011 /PRNewswire/ -- Gene Codes Corporation has pulled back the curtain on some key features in its upcoming release of Sequencher® with support for Next Generation Sequencing [NGS] data. At the annual meeting of the Association of Biomolecular Resource Facilities [ABRF] in San Antonio, Gene Codes showed alignments with paired and unpaired reads from SOLiD, Illumina and 454 instruments. Conference attendees were given hands-on experience calling some of the alignment and visualization algorithms and tools that had been published in peer-reviewed journals and are now incorporated into Sequencher. Since the conference ended, the phones at Gene Codes headquarters have been ringing with scientists wanting early access.

One of the conference attendees was Paul Morrison, Director of the Molecular Biology Core Facilities at Dana-Farber Cancer Institute and Associate Director of the Molecular Biology and Genomics Core Facility, Center for AIDS Research at Harvard University. "This is just what we always liked getting from Gene Codes," said Morrison who has been using Sequencher since 1992. "The interface is so clear and obvious that you don't really need someone to explain it."

Howard Cash, President of Gene Codes, said "Our focus at Gene Codes has always been on ease of use and building an intuitive and understandable interface to the software. This was just the next step in taking very complicated information and helping the user find their way through the data. We only showed some of what will be in Sequencher 5.0, and that is just the tip of the iceberg in terms of what NGS analysis functions we plan to add over the next two years."

Cash also noted that many did not immediately believe that the NGS version of Sequencher would not come at a higher price. "Several companies that had software to support capillary sequencing created a new program for NextGen data that their customer could buy. We had never done that before and I saw no reason to start now. When data moved from autorads to fluorescent sequencers in the early 90's, labs could produce a lot more data and we added a lot of functionality to Sequencher. Our clients who were already paying for support got those improvements as part of our regular service. I don't see why this is any different."

"We were overwhelmed with the response," said Catherine Murray, Gene Codes Marketing Manager. "Gene Codes' NGS software plans were part of the presentation when our president gave the opening keynote address at ABRF in Salt Lake City a few years ago. It's also been on our web site for months and we've sent out thousands of mailings, so we expected this not to surprise anyone." Asked what was brought up most by conference goers, Murray said, "It wasn't just seeing the speed of some of the algorithms being developed in the community. Attendees were excited about how we had integrated those algorithms into the Sequencher user experience. It's the feeling of using a familiar tool in a much more powerful way."

About Gene Codes Gene Codes Corporation (www.genecodes.com) is an international software firm specializing in bioinformatics software for DNA sequence analysis. Gene Codes' scientist-friendly software tools hold the dominant share in the DNA sequencing sector and are unrivaled in forensic DNA identification for mass fatalities.

Gene Codes' success is built on customer-driven product development, combining the latest programming techniques, rigorous quality control and an open dialogue with customers to produce products of the utmost usability and industry relevance.

As the popularity of Sequencher has grown, so has the company. Gene Codes is a motivated, enthusiastic, high-energy organization based in Ann Arbor, with offices in New York City and in Brighton, England. Gene Codes' corporate culture values flexible collaboration, shared responsibility, and dynamic change. Contact: Catherine Murray, Marketing Manager catie@genecodes.com (800) 497-4939
'/>"/>

SOURCE Gene Codes Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scientists from Toronto and Helsinki discover genetic abnormalities after creation of stem cells
2. With the Recent Launch of Novartiss Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch
3. New treatment for rabies advances after successful phase 1 trial in India
4. Lubricating the knee cartilage after ACL injury may prevent osteoarthritis
5. Women More Likely Than Men to Avoid Amputation After Minimally Invasive Therapy for Blocked Leg Arteries
6. Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
7. Rx100 Rescues Life if Administered Up to 72 Hours After Exposure to Lethal, Whole-Body Radiation!
8. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
9. Medicagos H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
10. ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
11. Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... San Francisco, CA (PRWEB) , ... February 21, ... ... is pleased to announce that Dr. Trevor Heritage has joined its executive team ... a revolutionary system designed to provide insights to help improve the diagnosis and ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... GMP cell therapy manufacturing facility at its headquarters laboratory in Poway, California. ... utilizing the experience of both in-house personnel and consultants, VetStem constructed and validated ...
(Date:2/21/2017)... a returning partner of the Amgen Tour of California , ... of the men,s and women,s events for the next five editions ... of California will mark the start of ... cycling teams in the world racing from Northern to ... from Heart Disease TM Women,s Race empowered with SRAM ...
(Date:2/21/2017)... 2017   Invitae Corporation (NYSE: NVTA), one ... that members of the company,s management team will present ... Conference on Monday, March 6, 2017 at approximately 4:00 ... Boston, Massachusetts . The live, ... visiting the investors section of the company,s website at ...
Breaking Biology Technology:
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):